Andrew T. Yan, MD; Raymond T. Yan, MD; Peter P. Liu, MD
Heart failure is an important cause of morbidity and mortality. Clinical trials over the past 2 decades have revolutionized the care of patients with systolic heart failure, and substantial data support the use of angiotensin-converting enzyme inhibitors, Î²-blockers, angiotensin-receptor blockers, and aldosterone blockers in the management of this serious condition. This article reviews the evidence on the pharmacologic treatment of heart failure, with a focus on recent clinical trials.
Learn more about subscription options.
Register Now for a free account.
Yan AT, Yan RT, Liu PP. Narrative Review: Pharmacotherapy for Chronic Heart Failure: Evidence from Recent Clinical Trials. Ann Intern Med. 2005;142:132-145. doi: 10.7326/0003-4819-142-2-200501180-00013
Download citation file:
Published: Ann Intern Med. 2005;142(2):132-145.
Cardiology, Coronary Risk Factors, Heart Failure, Hospital Medicine, Hypertension.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only